Detalhe da pesquisa
1.
Decreased HER2 expression in endometrial cancer following anti-HER2 therapy.
J Pathol
; 262(2): 129-136, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38013631
2.
A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2).
Gynecol Oncol
; 182: 75-81, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38262242
3.
The highs and lows of serous ovarian cancer.
Cancer
; 129(17): 2613-2620, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37366225
4.
Chemotherapy response in low-grade serous ovarian carcinoma at a comprehensive cancer center: Readdressing the roles of platinum and cytotoxic therapies.
Cancer
; 129(13): 2004-2012, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36951509
5.
HER2 Genetic Intratumor Heterogeneity Is Associated With Resistance to Trastuzumab and Trastuzumab Emtansine Therapy in Recurrent High-Grade Endometrial Cancer.
Mod Pathol
; 36(11): 100299, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37558129
6.
Interobserver Reproducibility in Assessing Eosinophilic Cells in Ovarian Serous Borderline Tumors to Predict BRAF Mutational Status.
Int J Gynecol Pathol
; 42(5): 472-481, 2023 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36867514
7.
Mullerian adenosarcoma: clinicopathologic and molecular characterization highlighting recurrent BAP1 loss and distinctive features of high-grade tumors.
Mod Pathol
; 35(11): 1684-1694, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36138078
8.
Histopathologic features and molecular genetic landscape of HER2-amplified endometrial carcinomas.
Mod Pathol
; 35(7): 962-971, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34972830
9.
Advancements in Low-Grade Serous Carcinoma of the Ovary and Peritoneum.
Curr Oncol Rep
; 24(11): 1549-1555, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35962920
10.
Characterization of TP53-wildtype tubo-ovarian high-grade serous carcinomas: rare exceptions to the binary classification of ovarian serous carcinoma.
Mod Pathol
; 34(2): 490-501, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32801341
11.
Exploring the clinical significance of serous tubal intraepithelial carcinoma associated with advanced high-grade serous ovarian cancer: A Memorial Sloan Kettering Team Ovary Study.
Gynecol Oncol
; 160(3): 696-703, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33386131
12.
High-Risk Human Papillomavirus-Associated Mixed Intestinal-Type Mucinous Adenocarcinoma and Low-grade Neuroendocrine Tumor of the Uterine Cervix: Report of a Case Harboring Shared ARID1A and SMAD4 Mutations Between Morphologically Distinct Components.
Int J Gynecol Pathol
; 2024 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38294060
13.
Beyond the estrogen receptor: In search of predictive biomarkers for low-grade serous ovarian cancer.
Cancer
; 129(9): 1305-1307, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36867575
14.
Loss of ARID1A expression in endometrial samplings is associated with the risk of endometrial carcinoma.
Gynecol Oncol
; 150(3): 426-431, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30126589
15.
Somatic BAP1 Loss in Ovarian Serous Borderline Tumor and Recurrent Low-grade Serous Carcinoma From a Germline BAP1 Mutation Carrier.
Int J Gynecol Pathol
; 42(4): 432-433, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36867467
16.
Loss of ALDH1A1 expression is an early event in the pathogenesis of ovarian high-grade serous carcinoma.
Mod Pathol
; 28(3): 437-45, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25216223
17.
Aneuploidy Landscape in Precursors of Ovarian Cancer.
Clin Cancer Res
; 30(3): 600-615, 2024 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38048050
18.
Morphologic and Molecular Heterogeneity of High-grade Serous Carcinoma Precursor Lesions.
Am J Surg Pathol
; 48(4): 475-486, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38298022
19.
Deep Interactive Learning-based ovarian cancer segmentation of H&E-stained whole slide images to study morphological patterns of BRCA mutation.
J Pathol Inform
; 14: 100160, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36536772
20.
Metastatic melanoma concurrent to the urinary bladder and endometrium: Case report.
J Med Imaging Radiat Oncol
; 66(5): 643-646, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34850582